4日前 -Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and ...
6日前 -Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the ...
2024/9/6 -We address the latest advancements in automatic text analysis with artificial intelligence (AI) in medicine, with a focus on its implications in aiding ...
【企業深層研究】エーザイ（下） エーザイの株価が冴えない。昨年来の株価は最高値が2023年6月の1万590円。以後はほぼ右肩下がり。8月2日に行った24年4～6月期の四半期決算では売上収益は1890億円で、前年同期比マイ...
日刊ゲンダイDIGITAL-
2024年10月2日（水）の日経平均株価をはじめ、日経平均寄与度の上位と下位銘柄、業種別騰落ランキング、東証プライム市場に上場している個別株式の騰落率ランキングなどをお伝えします。10月2日の日経平均株価は終日...
THE GOLD ONLINE（ゴールドオンライン）-
2024/9/24 -Eisai is a company that focuses not only on developing pharmaceuticals but also the potential of corporative activities that go beyond the provisio
2024/9/7 -Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD clinical trial.
2024/9/19 -Metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis with limited treatment options, especially after the use of androgen receptor (AR) ...
2024/9/6 -1008 位粉丝、已关注 2849 人、 317 篇帖子 - Instagram 用户 eisai (@eisai.s1016)：“✳︎日本デコラージュ協会クラフトマイスター認定講師✳︎KEA認定講師-実技講座 ...
2024/9/15 -Search Medical science liaison jobs in Remote with company ratings & salaries. 58 open jobs for Medical science liaison in Remote.
2024/9/21 -The global risks, benefits, and relevance of early-phases clinical trials participation for patients with hematological malignancies remain poorly evaluated.
2024/9/14 -BT8009 is a highly selective Bicycle® Toxin Conjugate targeting Nectin-4, which is overexpressed in mUC and other cancers. BT8009 has lower molecular weight and ...